Literature DB >> 9919866

The application of goal attainment scaling in chronic pain settings.

C Zaza1, P Stolee, K Prkachin.   

Abstract

Although the multidimensional nature of chronic pain has been recognized since the 1960s, pain management continues to reflect a biomedical model for many chronic pain patients. The application of a biopsychosocial approach would be aided by measurement tools that reflect the multidimensional nature of pain, facilitate interdisciplinary care planning, and focus treatment on the consequences of pain that are important to patients. Goal Attainment Scaling (GAS) is an individualized health outcome measure that is suitable for health problems that warrant a multidimensional and individualized approach to treatment planning and outcome measurement. This paper describes the use of GAS as a treatment and research tool in cancer pain, pediatric pain, work-related nonmalignant pain, and geriatric pain. Unlike the typical process where goals are not explicitly stated, GAS allows goals to be stated in a systematic measurable manner that is relevant and meaningful for each patient, and that can guide individual treatment planning. GAS is an appropriate technique for guiding and monitoring the treatment of individual chronic pain patients, and may provide a useful tool for evaluating chronic pain programs.

Entities:  

Mesh:

Year:  1999        PMID: 9919866     DOI: 10.1016/s0885-3924(98)00106-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  3 in total

Review 1.  Demographics, assessment and management of pain in the elderly.

Authors:  Mellar P Davis; Manish Srivastava
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

2.  The GOAL-Hēm journey: Shared decision making and patient-centred outcomes.

Authors:  Jonathan C Roberts; Sharon Richardson; Moses E Miles; Justin Stanley; Chere A T Chapman; Michael Denne; Jorge Caicedo; Kenneth Rockwood; Michael Recht
Journal:  Haemophilia       Date:  2022-06-21       Impact factor: 4.263

3.  Measuring Effects on Pain and Quality of Life after Abobotulinum Toxin A Injections in Children with Cerebral Palsy.

Authors:  Christian Wong; Ian Westphall; Josephine Sandahl Michelsen
Journal:  Toxins (Basel)       Date:  2022-01-05       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.